CELLDEX THERAPEUTICS INC NEW - COM (CLDX)

CUSIP: 15117B103

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class
Equity / COM
Total 13F shares
371,420
Share change
+286,128
Total reported value
$13,158,000
Price per share
$35.20
Number of holders
4
Value change
+$10,136,349
Number of buys
3

Quarterly Holders Quick Answers

What is CUSIP 15117B103?
CUSIP 15117B103 identifies CLDX - CELLDEX THERAPEUTICS INC NEW - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLDEX THERAPEUTICS INC NEW - COM (CLDX) as of Q3 2013

As of 30 Sep 2013, CELLDEX THERAPEUTICS INC NEW - COM (CLDX) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 371,420 shares. The largest 4 holders included Citadel Advisors LLC, WELLS FARGO & COMPANY/MN, Elite Wealth Management, LLC, and HUNTINGTON NATIONAL BANK. This page lists 4 institutional shareholders reporting positions in this security for the Q3 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.